Invest in the Future of Cancer Diagnostics
We are raising a €5M equity Seed Round to scale our business and impact – up to 50% committed by the EIC. If you want to support our mission, now is the time to join.
Why Better Medicine
Pioneering in the abdomen, specialising in oncology
Abdominal cancers have no screening programme, and around 80% of stomach and pancreatic cases are already advanced when found.1 Yet they are often visible earlier – on the 400+ million CT scans taken worldwide each year for unrelated reasons.2 Over 60% of renal cancers are found incidentally, and a third of the missed ones had been overlooked more than once.3
Regulatory head start
The world’s first and only CE-certified, clinically validated AI for kidney cancer detection under EU MDR. It is the first module of our abdominal suite, with liver, pancreas and lymph nodes coming next.
Proprietary technology for every next AI
Our multi-modal foundational model – proprietary, patent-pending technology pretrained on CTs, reports and metadata – cuts time-to-market for each new organ module and raises robustness.
Competitors become partners
Rather than compete organ by organ, we license third-party AI for lung, breast, prostate and brain and sell it alongside our own – the route from kidney, to the abdomen, to full-body opportunistic screening.
1. Stage-at-diagnosis figures: Johns Hopkins Medicine; City of Hope. 2. UNSCEAR 2020/2021 Report, Annex A (2022), Evaluation of Medical Exposure to Ionizing Radiation. 3. Bradley A.J. (2021), Routes to diagnosis and missed opportunities in the detection of renal cancer, Clinical Radiology 76(2), 129–134.
Clinically Proven
Validated in a blinded multi-reader study with Nature Communications Medicine –
and deployed in European clinics today
Clinical evidence
Deployment traction
Economic modelling
Source: Petryshak et al., A clinically validated AI framework for kidney cancer detection and characterization, Nature Communications Medicine. Health-economic assessment conducted in Estonia.
The Round
€5M equity Seed – up to 50% committed by the EIC
Our beachhead model puts BMVision on routine CTs under hospital site budgets, with a clear path to insurer-funded scale at a significant pricing uplift. The Seed Round takes us from certified kidney AI to a certified multi-organ abdominal suite.
The Team
A passionate founding team of doctors, AI experts & entrepreneurs – the team that shipped the world’s first certified kidney cancer AI
Priit Salumaa
Co-Founder & Chief Executive Officer
Serial entrepreneur, founded two successful tech companies. Involved in building products for Wise, Bolt & Playtech.
Dmytro Fishman
Co-Founder & Chief Science Officer
Publishing in Nature Methods & Cell. Leading a medical imaging research group at University of Tartu.
Helena Ije
Co-Founder & Chief Operating Officer
Strong operational background in pharmaceuticals and digital health having worked together with the NHS to launch services in the UK.
Bohdan Petryshak
Co-Founder & Chief of AI Engineering
1st place in Microsoft AI for Good Idea Challenge. Better Medicine is his 2nd medical imaging startup.
Backed by an advisory team of medical, insurance & industry experts
Dr. Martin Reim
Co-Founder, Medical Advisor
Vice-President of the Estonian Radiology Society. National representative at the Atomic Energy Agency.
Dr. Jaideep S. Sohi
Medical Advisor
CEO, American Molecular Imaging. Clinical Assistant Professor, Northwestern University. Leading nuclear medicine radiologist in the US.
Wido Menhardt
Industry Advisor
Former Executive VP, Siemens Healthineers – ran their digital health products.
Dr. Stephan Binder
Industry Advisor
Co-Founder and COO of Kalms Consulting. Nearly 20 years advising on medical devices, diagnostics, healthcare IT and hospital workflows.
Kai Siinmaa
Healthcare Market Advisor
Founder of Baltic HC Solutions. Medical doctor by training, previously at Janssen (Johnson & Johnson) and Merck.
Thomas Doyle
Insurance Advisor
Chair and Independent Supervisory Board Member, Austrian Life.
Ants Nõmper
Legal Advisor
Partner at Ellex Raidla. Leading medical and IP expert in Estonia.
